Characterizing cancer cachexia in the geriatric oncology population

Richard F. Dunne, Breton Roussel, Eva Culakova, Chintan Pandya, Fergal J. Fleming, Bradley Hensley, Allison M. Magnuson, Kah Poh Loh, Maxence Gilles, Erika Ramsdale, Ronald Maggiore, Aminah Jatoi, Karen M. Mustian, William Dale, Supriya G. Mohile

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: Cancer cachexia, characterized by weight loss and sarcopenia, leads to a decline in physical function and is associated with poorer survival. Cancer cachexia remains poorly described in older adults with cancer. This study aims to characterize cancer cachexia in older adults by assessing its prevalence utilizing standard definitions and evaluating associations with components of the geriatric assessment (GA) and survival. Materials and Methods: Patients with cancer older than 65 years of age who underwent a GA and had baseline CT imaging were eligible in this cross-sectional study. Cancer cachexia was defined by the international consensus definition reported in 2011. Sarcopenia was measured using cross-sectional imaging and utilizing sex-specific cut-offs. Associations between cachexia, sarcopenia, and weight loss with survival and GA domains were explored. Results: Mean age of 100 subjects was 79.9 years (66–95) and 65% met criteria for cancer cachexia. Cachexia was associated with impairment in instrumental activities of daily living (IADL) (p =.017); no significant association was found between sarcopenia or weight loss and IADL impairment. Cachexia was significantly associated with poorer survival (median 1.0 vs 2.1 years, p =.011). Conclusions: Cancer cachexia as defined by the international consensus definition is prevalent in older adults with cancer and is associated with functional impairment and decreased survival. Larger prospective studies are needed to further describe cancer cachexia in this population.

Original languageEnglish (US)
JournalJournal of Geriatric Oncology
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Cachexia
Geriatrics
Sarcopenia
Population
Neoplasms
Geriatric Assessment
Survival
Weight Loss
Activities of Daily Living
Cross-Sectional Studies
Prospective Studies

Keywords

  • Cachexia
  • Functional impairment
  • Geriatric assessment
  • Geriatric oncology
  • Sarcopenia
  • Weight loss

ASJC Scopus subject areas

  • Oncology
  • Geriatrics and Gerontology

Cite this

Dunne, R. F., Roussel, B., Culakova, E., Pandya, C., Fleming, F. J., Hensley, B., ... Mohile, S. G. (Accepted/In press). Characterizing cancer cachexia in the geriatric oncology population. Journal of Geriatric Oncology. https://doi.org/10.1016/j.jgo.2018.08.008

Characterizing cancer cachexia in the geriatric oncology population. / Dunne, Richard F.; Roussel, Breton; Culakova, Eva; Pandya, Chintan; Fleming, Fergal J.; Hensley, Bradley; Magnuson, Allison M.; Loh, Kah Poh; Gilles, Maxence; Ramsdale, Erika; Maggiore, Ronald; Jatoi, Aminah; Mustian, Karen M.; Dale, William; Mohile, Supriya G.

In: Journal of Geriatric Oncology, 01.01.2018.

Research output: Contribution to journalArticle

Dunne, RF, Roussel, B, Culakova, E, Pandya, C, Fleming, FJ, Hensley, B, Magnuson, AM, Loh, KP, Gilles, M, Ramsdale, E, Maggiore, R, Jatoi, A, Mustian, KM, Dale, W & Mohile, SG 2018, 'Characterizing cancer cachexia in the geriatric oncology population', Journal of Geriatric Oncology. https://doi.org/10.1016/j.jgo.2018.08.008
Dunne, Richard F. ; Roussel, Breton ; Culakova, Eva ; Pandya, Chintan ; Fleming, Fergal J. ; Hensley, Bradley ; Magnuson, Allison M. ; Loh, Kah Poh ; Gilles, Maxence ; Ramsdale, Erika ; Maggiore, Ronald ; Jatoi, Aminah ; Mustian, Karen M. ; Dale, William ; Mohile, Supriya G. / Characterizing cancer cachexia in the geriatric oncology population. In: Journal of Geriatric Oncology. 2018.
@article{3f2aab3e76ef452eb7f0dd5642925600,
title = "Characterizing cancer cachexia in the geriatric oncology population",
abstract = "Objectives: Cancer cachexia, characterized by weight loss and sarcopenia, leads to a decline in physical function and is associated with poorer survival. Cancer cachexia remains poorly described in older adults with cancer. This study aims to characterize cancer cachexia in older adults by assessing its prevalence utilizing standard definitions and evaluating associations with components of the geriatric assessment (GA) and survival. Materials and Methods: Patients with cancer older than 65 years of age who underwent a GA and had baseline CT imaging were eligible in this cross-sectional study. Cancer cachexia was defined by the international consensus definition reported in 2011. Sarcopenia was measured using cross-sectional imaging and utilizing sex-specific cut-offs. Associations between cachexia, sarcopenia, and weight loss with survival and GA domains were explored. Results: Mean age of 100 subjects was 79.9 years (66–95) and 65{\%} met criteria for cancer cachexia. Cachexia was associated with impairment in instrumental activities of daily living (IADL) (p =.017); no significant association was found between sarcopenia or weight loss and IADL impairment. Cachexia was significantly associated with poorer survival (median 1.0 vs 2.1 years, p =.011). Conclusions: Cancer cachexia as defined by the international consensus definition is prevalent in older adults with cancer and is associated with functional impairment and decreased survival. Larger prospective studies are needed to further describe cancer cachexia in this population.",
keywords = "Cachexia, Functional impairment, Geriatric assessment, Geriatric oncology, Sarcopenia, Weight loss",
author = "Dunne, {Richard F.} and Breton Roussel and Eva Culakova and Chintan Pandya and Fleming, {Fergal J.} and Bradley Hensley and Magnuson, {Allison M.} and Loh, {Kah Poh} and Maxence Gilles and Erika Ramsdale and Ronald Maggiore and Aminah Jatoi and Mustian, {Karen M.} and William Dale and Mohile, {Supriya G.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jgo.2018.08.008",
language = "English (US)",
journal = "Journal of Geriatric Oncology",
issn = "1879-4068",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Characterizing cancer cachexia in the geriatric oncology population

AU - Dunne, Richard F.

AU - Roussel, Breton

AU - Culakova, Eva

AU - Pandya, Chintan

AU - Fleming, Fergal J.

AU - Hensley, Bradley

AU - Magnuson, Allison M.

AU - Loh, Kah Poh

AU - Gilles, Maxence

AU - Ramsdale, Erika

AU - Maggiore, Ronald

AU - Jatoi, Aminah

AU - Mustian, Karen M.

AU - Dale, William

AU - Mohile, Supriya G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objectives: Cancer cachexia, characterized by weight loss and sarcopenia, leads to a decline in physical function and is associated with poorer survival. Cancer cachexia remains poorly described in older adults with cancer. This study aims to characterize cancer cachexia in older adults by assessing its prevalence utilizing standard definitions and evaluating associations with components of the geriatric assessment (GA) and survival. Materials and Methods: Patients with cancer older than 65 years of age who underwent a GA and had baseline CT imaging were eligible in this cross-sectional study. Cancer cachexia was defined by the international consensus definition reported in 2011. Sarcopenia was measured using cross-sectional imaging and utilizing sex-specific cut-offs. Associations between cachexia, sarcopenia, and weight loss with survival and GA domains were explored. Results: Mean age of 100 subjects was 79.9 years (66–95) and 65% met criteria for cancer cachexia. Cachexia was associated with impairment in instrumental activities of daily living (IADL) (p =.017); no significant association was found between sarcopenia or weight loss and IADL impairment. Cachexia was significantly associated with poorer survival (median 1.0 vs 2.1 years, p =.011). Conclusions: Cancer cachexia as defined by the international consensus definition is prevalent in older adults with cancer and is associated with functional impairment and decreased survival. Larger prospective studies are needed to further describe cancer cachexia in this population.

AB - Objectives: Cancer cachexia, characterized by weight loss and sarcopenia, leads to a decline in physical function and is associated with poorer survival. Cancer cachexia remains poorly described in older adults with cancer. This study aims to characterize cancer cachexia in older adults by assessing its prevalence utilizing standard definitions and evaluating associations with components of the geriatric assessment (GA) and survival. Materials and Methods: Patients with cancer older than 65 years of age who underwent a GA and had baseline CT imaging were eligible in this cross-sectional study. Cancer cachexia was defined by the international consensus definition reported in 2011. Sarcopenia was measured using cross-sectional imaging and utilizing sex-specific cut-offs. Associations between cachexia, sarcopenia, and weight loss with survival and GA domains were explored. Results: Mean age of 100 subjects was 79.9 years (66–95) and 65% met criteria for cancer cachexia. Cachexia was associated with impairment in instrumental activities of daily living (IADL) (p =.017); no significant association was found between sarcopenia or weight loss and IADL impairment. Cachexia was significantly associated with poorer survival (median 1.0 vs 2.1 years, p =.011). Conclusions: Cancer cachexia as defined by the international consensus definition is prevalent in older adults with cancer and is associated with functional impairment and decreased survival. Larger prospective studies are needed to further describe cancer cachexia in this population.

KW - Cachexia

KW - Functional impairment

KW - Geriatric assessment

KW - Geriatric oncology

KW - Sarcopenia

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=85052834427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052834427&partnerID=8YFLogxK

U2 - 10.1016/j.jgo.2018.08.008

DO - 10.1016/j.jgo.2018.08.008

M3 - Article

C2 - 30196027

AN - SCOPUS:85052834427

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

SN - 1879-4068

ER -